You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
703 Single cell analysis of phase II study of nivolumab and relatlimab in metastatic uveal melanoma reveals tumor and immune response to dual PD-1 and LAG-3 inhibition

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023236016
Dec 20235607
Jan 20245905
Feb 20245203
Mar 20245205
Apr 20245204
May 20242003
Jun 20241806
Jul 20241600
Aug 20242604
Sep 20243204
Oct 20242604
Nov 20244001
Dec 20242003
Jan 20253005
Feb 2025605
Mar 20250012
Apr 2025102
May 2025002
Jun 2025003
Total742094